Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-05 to 2023-01-06
Current total value of award: $16316.09
Description: 4559572453!REBLOZYL 75 MG VIALS